Ketamine Therapy Offers Hope for People with Treatment Resistant PTSD
Last reviewed and updated: August 16, 2026.
Key Takeaways
| The use | Ketamine is used off-label for PTSD, including treatment-resistant PTSD, especially when standard treatments have failed. |
| The evidence | Some randomized trials show ketamine can rapidly reduce PTSD symptoms, though benefits can be transient and results across studies are mixed. |
| Not FDA-approved for PTSD | Ketamine and Spravato are not FDA-approved for PTSD. IV ketamine for PTSD is off-label and generally paid out of pocket. |
| Why it appeals | Ketamine acts fast and affects fear and mood processing, which makes it attractive when conventional PTSD treatments do not work. |
| The 2026 landscape | With MDMA therapy rejected in 2024 and being redesigned, ketamine remains the most accessible option for treatment-resistant PTSD. |
Because ketamine for PTSD is off-label, cost is a central issue, and our clinic inquiry data shows why.
A recent study published in Nature Mental Health highlights the potential of ketamine-assisted therapy to help people living with severe post-traumatic stress disorder. In a controlled clinical setting, participants who had not responded to other treatments showed significant improvement after receiving repeated doses of ketamine in combination with psychotherapy.
New: Interested in Being Part of a Psychedelics-Focused Clinical Trial? Sign Up Here
| Key Takeaways | Details |
|---|---|
| Condition treated | Treatment resistant PTSD |
| Substance used | Ketamine |
| Therapy approach | Psychedelic style setting with music, eye masks and guided integration |
| Number of participants | 158 adults |
| Dosing schedule | Six ketamine infusions over two weeks plus talk therapy |
| Main result | Significant reduction in PTSD symptoms that lasted at least 24 days |
| Broader implication | Ketamine may serve as a powerful tool when paired with the right support |
RELATED: Watch: WSJ Breaks Down the Mainstreaming of Psychedelics in Silicon Valley
How the Treatment Was Structured
The trial involved 158 adults diagnosed with treatment resistant PTSD. Each received either a low dose of ketamine, a standard dose or a placebo across six sessions. Participants also took part in guided therapy that followed each infusion. This included talk therapy as well as structured time for emotional processing.
Researchers created a setting designed to support introspection and calm. Participants wore eye masks and listened to curated music during infusions. These features mirrored aspects of other psychedelic therapies that aim to soften mental defenses and encourage emotional breakthroughs.
RELATED: Federal Judge Orders Utah Police to Return Psychedelic Mushrooms to Religious Group
Results Show Sustained Symptom Relief
Participants who received the higher dose of ketamine showed the strongest reduction in PTSD symptoms. In many cases, these effects lasted weeks after the final treatment. That durability suggests ketamine may work not just by blocking symptoms temporarily but by helping the brain reorganize emotional memory.
The researchers note that this therapeutic model does more than simply deliver a drug. It offers a space where patients can revisit trauma with a new mindset. Therapy sessions before and after infusions help ground the experience and turn it into something constructive.
RELATED: A Scientist Just Created A New Giant, Mutant Magic Mushroom
A New Direction for Trauma Care
Though ketamine is already used for depression in some clinics, its benefits for PTSD have been harder to confirm. This study offers some of the strongest data to date that the substance may be effective when delivered in the right context.
The research supports a broader move toward treatments that view mental health as a whole body and mind experience. By pairing medicine with meaning, ketamine assisted therapy may offer new hope for people who have tried everything else.
RELATED: Magic Mushrooms Court Ruling Could Reshape India’s Drug Laws: “It’s A Natural Fungus”
Ketamine for Treatment-Resistant PTSD in 2026
Ketamine is used off-label for PTSD, including treatment-resistant PTSD. Some randomized trials show it can rapidly reduce symptoms, including a controlled trial of repeated ketamine infusions for chronic PTSD. The overall picture stays mixed. Benefits can be transient, results across studies vary, and researchers have tested repeated infusions to extend the effect. Ketamine acts fast and affects fear and mood processing. Those qualities make it appealing when standard treatments fail.
Ketamine is not FDA-approved for PTSD. Spravato (esketamine) is approved for treatment-resistant depression, not PTSD. Because IV ketamine for PTSD is off-label, patients almost always pay out of pocket. Sessions commonly run about $300 to $500 each. That cost barrier connects directly to the inquiry data above, where most patients arrive with no insurance pathway.
The wider landscape shapes ketamine’s role. The FDA rejected MDMA-assisted therapy for PTSD in August 2024, and developers are now redesigning it. Ketamine therefore remains the most accessible option for treatment-resistant PTSD while other psychedelics move through trials. The VA is studying psychedelics, including ketamine, for veterans. Ketamine is a real but imperfect option, and it works best with psychological support and realistic expectations.
Frequently Asked Questions
- Does ketamine help with PTSD?
- Some randomized trials show ketamine can rapidly reduce PTSD symptoms, including in treatment-resistant PTSD. However, benefits can be transient and results across studies are mixed, so it is not a guaranteed or permanent fix. Repeated infusions have been studied to extend the effect. Ketamine tends to work best alongside psychological support.
- Is ketamine FDA-approved for PTSD?
- No. Ketamine is used off-label for PTSD, and Spravato (esketamine) is FDA-approved for treatment-resistant depression, not PTSD. Because IV ketamine for PTSD is off-label, it is almost never covered by insurance and is generally paid out of pocket, commonly around $300 to $500 per session.
- Why do people use ketamine for PTSD if it is not approved?
- Ketamine acts quickly and affects fear and mood processing, which makes it appealing when standard PTSD treatments fail. With MDMA-assisted therapy rejected by the FDA in 2024 and being redesigned, ketamine remains one of the most accessible rapid-acting options for treatment-resistant PTSD, even though it is used off-label.
- How much does ketamine for PTSD cost?
- Because it is off-label, ketamine for PTSD is almost never covered by insurance. IV ketamine sessions commonly run about $300 to $500 each, and clinics often use a series of sessions. Our data shows about 75 percent of patients inquiring about ketamine have no insurance pathway, so cost is a major barrier.
